Virtual Screening of Marine Natural Products Targeting the F Protein for Anti-RSV Drug Discovery
International Journal of Molecular Sciences · 08.03.2026 · 27 (5) · 2484
DOI: 10.3390/ijms27052484 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.03.2026. Verfasst von Wenqing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Marine Drugs and Key Laboratory of Evolution and Marine Biodiversity, Institute of Evolution & Marine Biodiversity, School of M…. Hauptthemen laut MEDLINE: Biological Products, Antiviral Agents, Drug Discovery, Viral Fusion Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) poses a substantial global health burden, particularly in infants and the elderly. The fusion (F) protein is a key therapeutic target for inhibiting RSV entry. In this study, we performed a structure-based virtual screening of the Comprehensive Marine Natural Products Database (CMNPD) to discover novel anti-RSV agents targeting the prefusion F protein trimer. Screening of 31,561 compounds via molecular docking, followed by stringent ADMET (absorption, distribution, metabolism, excretion, and toxicity) profiling and MM/GBSA (Molecular Mechanics/Generalized Born Surface Area) binding free energy calculations, identified 11 promising candidates. Among these, manzamine alkaloids exhibited the most favorable docking scores (as low as −13.3 kcal/mol) and promising Ligand Efficiency (LE) values. These molecules primarily interact with conserved hydrophobic residues (Phe140, Phe488) through hydrophobic interactions, π-stacking, and electrostatic forces. Our study highlights marine natural products, especially manzamine alkaloids, as promising leads for the development of novel, orally bioavailable RSV fusion inhibitors, potentially offering avenues to overcome existing drug resistance. However, these computational findings require in vitro validation to confirm efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Marine Drugs and Key Laboratory of Evolution and Marine Biodiversity, Institute of Evolution & Marine Biodiversity, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China.
- Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
- Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao 266114, China.
ORCID-Profile: Ruikun Du, Zhiqing Liu, Pingyuan Wang
Förderung
- the National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Liu, W., Gu, X., Du, R., Liu, Z., Wang, P., & Wang, C. Y. (2026). Virtual Screening of Marine Natural Products Targeting the F Protein for Anti-RSV Drug Discovery. International Journal of Molecular Sciences, 27(5), 2484. https://doi.org/10.3390/ijms27052484
Vancouver
Liu W, Gu X, Du R, Liu Z, Wang P, Wang CY. Virtual Screening of Marine Natural Products Targeting the F Protein for Anti-RSV Drug Discovery. International Journal of Molecular Sciences. 2026;27(5):2484. doi:10.3390/ijms27052484
BibTeX
@article{Liu2026,
author = {Liu, Wenqing and Gu, Xuran and Du, Ruikun and Liu, Zhiqing and Wang, Pingyuan and Wang, Chang-Yun},
title = {Virtual Screening of Marine Natural Products Targeting the F Protein for Anti-RSV Drug Discovery},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {5},
pages = {2484},
doi = {10.3390/ijms27052484}
}
EUVIMED